Market Overview:
The global sepsis diagnostic products market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of sepsis, rising demand for rapid and accurate diagnosis of sepsis, and technological advancements in the field of diagnostics. The blood culture media segment is expected to account for the largest share of the global sepsis diagnostic products market in 2018. This segment is driven by the growing demand for rapid and accurate diagnosis of sepsis, which can be achieved through blood culture media. The assays & reagents segment is projected to grow at the highest CAGR during the forecast period. This growth can be attributed to increasing demand for advanced assays & reagents that help improve accuracy and speed up diagnosis of sepsis.
Product Definition:
Sepsis Diagnostic Products are used to diagnose sepsis, a potentially life-threatening condition caused by infection. The products may include blood tests, imaging tests, and other measures to assess the body's response to infection. Sepsis Diagnostic Products are important because they can help identify people who need treatment for sepsis as quickly as possible.
Blood Culture Media:
Blood culture media is a set of solutions and reagents used for growing microorganisms in blood samples. It helps detect the presence of bacteria, fungi, viruses or other pathogens in the blood sample. The most commonly used products are Pertinent Solutions (PS) and MacConkey Plus Agar (MPA).
Assays & Reagents:
Assays & reagents are used in the diagnosis of diseases to determine the presence or absence of a particular disease and also to check if a certain drug is effective for that disease. In sepsis diagnostic products, they are used for testing blood, urine, and other body fluids for the presence of specific bacteria or toxins.
The global assay & reagents market is expected to witness significant growth over the forecast period owing to increasing demand from hospitals.
Application Insights:
Based on the application, the global sepsis diagnostic products market is segmented into hospitals, pathology and reference laboratories and others. Hospitals are expected to be at the forefront of this market owing to their critical role in diagnosis of sepsis-related conditions. Furthermore, hospitals are considered as key institutions for research due to wide patient base & availability of samples for study. However, a decline in healthcare spending by governments across developed countries may hinder industry growth over the forecast period.
Sepsis often has a subtle presentation resulting in inadequate diagnosis or misdiagnosis which can lead to complications down the line such as multi-organ failure & death if untreated or mistreated respectively (1). The aforementioned factors have led to increased demand for sensitive and rapid diagnostic tools that help overcome these challenges while diagnosing sepsis with high accuracy thereby contributing towards overall revenue generation capacity over projected years (2).
Regional Analysis:
North America dominated the global sepsis diagnostic products market in 2017. This can be attributed to the presence of a large number of players, increasing awareness about early diagnosis, and availability of advanced treatment options for patients suffering from this condition. The U.S.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to improving healthcare infrastructure & facilities along with growing awareness among people pertaining to available diagnostic tools & procedures for early disease detection.
Growth Factors:
- Increasing incidence of sepsis: The incidence of sepsis is increasing at an alarming rate across the globe. This is primarily due to the increase in number of patients suffering from chronic diseases such as diabetes, cancer, and AIDS.
- Growing demand for early diagnosis and treatment: There is a growing demand for early diagnosis and treatment of sepsis among healthcare professionals worldwide. This has led to the development of novel diagnostic products that can help in early detection and treatment of sepsis.
- Technological advancements: The Sepsis Diagnostic Products market is witnessing rapid technological advancements, with manufacturers introducing innovative products that are capable of providing accurate results within minutes. This is helping to improve patient outcomes by enabling timely diagnosis and treatment decisions.
Scope Of The Report
Report Attributes
Report Details
Report Title
Sepsis Diagnostic Products Market Research Report
By Type
Blood Culture Media, Assays & Reagents, Instruments, Software
By Application
Hospitals, Pathology & Reference Laboratories
By Companies
bioMerieux (France), Danaher (US), Becton, Dickinson and Company (US), Roche (Switzerland), Abbott (US), T2 Biosystems (US), Luminex (US), Thermo Fisher Scientific (US), Bruker (US), CytoSorbents (US), bioMerieux (France)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
213
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global Sepsis Diagnostic Products Market Report Segments:
The global Sepsis Diagnostic Products market is segmented on the basis of:
Types
Blood Culture Media, Assays & Reagents, Instruments, Software
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Pathology & Reference Laboratories
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- bioMerieux (France)
- Danaher (US)
- Becton, Dickinson and Company (US)
- Roche (Switzerland)
- Abbott (US)
- T2 Biosystems (US)
- Luminex (US)
- Thermo Fisher Scientific (US)
- Bruker (US)
- CytoSorbents (US)
- bioMerieux (France)
Highlights of The Sepsis Diagnostic Products Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Blood Culture Media
- Assays & Reagents
- Instruments
- Software
- By Application:
- Hospitals
- Pathology & Reference Laboratories
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Sepsis Diagnostic Products Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Sepsis Diagnostic Products is a medical device company that manufactures and sells point-of-care devices for the diagnosis of sepsis. Sepsis Diagnostic Products' products include the Sepsis Rapid Test, which is a rapid diagnostic test for the detection of sepsis; and the Sepsis Thermometer, which is a handheld thermometer used to measure body temperature in patients with suspected or confirmed sepsis.
Some of the key players operating in the sepsis diagnostic products market are bioMerieux (France), Danaher (US), Becton, Dickinson and Company (US), Roche (Switzerland), Abbott (US), T2 Biosystems (US), Luminex (US), Thermo Fisher Scientific (US), Bruker (US), CytoSorbents (US), bioMerieux (France).
The sepsis diagnostic products market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Sepsis Diagnostic Products Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Sepsis Diagnostic Products Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Sepsis Diagnostic Products Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Sepsis Diagnostic Products Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Sepsis Diagnostic Products Market Size & Forecast, 2020-2028
4.5.1 Sepsis Diagnostic Products Market Size and Y-o-Y Growth
4.5.2 Sepsis Diagnostic Products Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Blood Culture Media
5.2.2 Assays & Reagents
5.2.3 Instruments
5.2.4 Software
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Pathology & Reference Laboratories
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Sepsis Diagnostic Products Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Sepsis Diagnostic Products Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Blood Culture Media
9.6.2 Assays & Reagents
9.6.3 Instruments
9.6.4 Software
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Pathology & Reference Laboratories
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Blood Culture Media
10.6.2 Assays & Reagents
10.6.3 Instruments
10.6.4 Software
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Pathology & Reference Laboratories
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Blood Culture Media
11.6.2 Assays & Reagents
11.6.3 Instruments
11.6.4 Software
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Pathology & Reference Laboratories
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Blood Culture Media
12.6.2 Assays & Reagents
12.6.3 Instruments
12.6.4 Software
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Pathology & Reference Laboratories
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Blood Culture Media
13.6.2 Assays & Reagents
13.6.3 Instruments
13.6.4 Software
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Pathology & Reference Laboratories
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Sepsis Diagnostic Products Market: Competitive Dashboard
14.2 Global Sepsis Diagnostic Products Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 bioMerieux (France)
14.3.2 Danaher (US)
14.3.3 Becton, Dickinson and Company (US)
14.3.4 Roche (Switzerland)
14.3.5 Abbott (US)
14.3.6 T2 Biosystems (US)
14.3.7 Luminex (US)
14.3.8 Thermo Fisher Scientific (US)
14.3.9 Bruker (US)
14.3.10 CytoSorbents (US)
14.3.11 bioMerieux (France)
